Showing results (71-80 of 83) with videos related to
Sort By:
Pageof 9
The British Journal of Psychiatry : the Journal of Mental Science|February 3, 2004
Prevalence of DSM-IV psychiatric disorder in the French elderly populationK Ritchie, S Artero, I Beluche, et al.Archives of General Psychiatry|February 1, 1989
Behavioral and physiologic effects of short-term and long-term administration of clonidine in panic disorderT W Uhde, M B Stein, B J Vittone, et al.L'Encephale|August 21, 2013
[The clinic of apathy in schizophrenia: a critical review of the issue]H Yazbek, S Raffard, J Del-Monte, et al.Journal of Psychosomatic Research|October 17, 2001
The influence of Type A behavior pattern on the response to the panicogenic agent CCK-4J M Le Mellédo, H Arthur, J Dalton, et al.Psychiatry Research|July 1, 1984
The sleep of patients with panic disorder: a preliminary reportT W Uhde, P Roy-Byrne, J C Gillin, et al.Psychopathology|January 1, 1984
Fear and anxiety: relationship to noradrenergic functionT W Uhde, J P Boulenger, R M Post, et al.European Journal of Pharmacology|March 17, 1992
Central benzodiazepine receptors in human brain: estimation of regional Bmax and KD values with positron emission tomographyP Abadie, J C Baron, J C Bisserbe, et al.Human Genetics|August 22, 2002
Functional characterization of the new human GABA(A) receptor mutation beta3(R192H)Andreas Buhr, Matt T Bianchi, Roland Baur, et al.Psychopharmacology|January 1, 1989
Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levelsJ C Baron, J L Martinot, H Cambon, et al.The American Journal of Psychiatry|January 1, 1990
Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patientsJ L Martinot, P Peron-Magnan, J D Huret, et al.Pageof 9